The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical landscape . Although its initial success and impact of billions in revenue , the intellectual property end has opened the way for competing medications, substantially diminishing profit prospects . This change raise